Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109252984 | 10925298 | 4 | F | 20160909 | 20150318 | 20160914 | PER | US-PFIZER INC-2015094298 | PFIZER | 82.00 | YR | M | Y | 0.00000 | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109252984 | 10925298 | 1 | PS | LYRICA | PREGABALIN | 1 | 50 MG, 3X/DAY | J05186 | 21446 | 50 | MG | TID | |||||||
| 109252984 | 10925298 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | 300 MG, 3X/DAY | 20235 | 300 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109252984 | 10925298 | 1 | Pain in extremity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109252984 | 10925298 | Drug ineffective | |
| 109252984 | 10925298 | Eye disorder | |
| 109252984 | 10925298 | Foot deformity | |
| 109252984 | 10925298 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109252984 | 10925298 | 1 | 20131010 | 0 |